CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2019

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

 

 

 

 

 

 

 

 

 

 

 

To Comare The Efficacy Of Dorzolamide 2% Timolol 0.5%Fixed Combination Versus Brinzolamide 1% Brimonidine 0.2% Fixed Combination Theray In Patients Of Primary Open Angle Glaucoma

Author: 
Dr. Anil Pathak, Dr. Veer Davinder Singh, Dr. Gursatinder Singh and Dr. Reagan Madan
Subject Area: 
Health Sciences
Abstract: 

A study was done to compare the efficacy of dorzolamide 2% timolol 0.5%fixed combination versus brinzolamide 1% brimonidine 0.2% fixed combination therapy in patients of primary open angle glaucoma. A randomized, open label, comparative, parallel group study was conducted on 40 patients of POAG attending the Outpatient Department of Ophthalmology, Government Medical College, Patiala. Patients selected were then randomised into two groups of 20 each. Baseline IOP was recorded at 9 am and 11 am on day 0 of the study.Group A: Fixed drug combination of Dorzolamide2%/ Timolol 0.5% (DTFC) dosed twice daily at 9 am and 9 pm .This group instilled 1 drop of DTFC ophthalmic solution into study eye twice daily at 9.00 a.m. and 9.00 p.m. for 6 weeks. Group B: Fixed drug combination of Brinzolamide 1%/ Brimonidine 0.2% (BBFC) dosed twice daily at 9 am and 9 pm. This group instilled 1 drop of BBFC ophthalmic solution into study eye twice daily at 9.00 a.m. and 9.00 p.m. for 6 weeks. Patients were then called for follow up at 2nd week, 4th week and 6th week during the study period and IOP recorded at 9 am and 11 am in the OPD. In Group A (DTFC), mean IOP at visit 1 ( baseline) at 9:00 AM was 27.00 ± 1.78 mm Hg, at 11:00 AM was 27.50 ± 1.91 mm Hg and mean IOP at all time points was 27.25 ± 1.81 mm Hg. There was no statistically significant variation in the mean IOP at any of the follow up visit in group A (p > 0.05). In Group B (BBFC), mean IOP at visit 1 ( baseline) at 9:00 AM was 26.85 ± 1.98 mm Hg, at 11:00 AM was 27.10 ± 2.17 mm Hg and mean IOP at all time points was 26.98 ± 2.04 mm Hg.There was no statistically significant variation in the mean IOP at any of the follow up visit in group A (p > 0.05).The reduction in mean IOP at visit 6 weeks in group A (DTFC) was 10.32 mm Hg (37.87%) and in group B (BBFC) was 9.50 mm Hg (35.21%). The reduction in mean IOP was comparable between the two groups. The difference was statistically non significant (p > 0.05).

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

 

 

 

 

 

 

 

 

 

 

 

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran